GSK Menu 60 Seconds of Science Welcome to the golden age of vaccine innovation 3D remodelled DNA helix structure Press releases 27 September 2017 GSK receives approval for Benlysta in Japan for the treatment of systemic lupus erythematosus 20 September 2017 GSK and Innoviva report positive headline results from IMPACT study showing single inhaler triple therapy Trelegy Ellipta reduced COPD exacerbations 18 September 2017 Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US View all press releases London 1,520.36 +31.86 Share price at 17:11 LSE price updated every 15 minutes. Timezone BST NYSE 40.91 +0.31 Share price at 16:02 NYSE price updated every 20 minutes. Timezone EST Tweets from GSK GSK @GSK 4 yrs ago we launched the first Ellipta inhaler. Here's the team celebrating the 100 millionth! The story behind it… twitter.com/i/web/status/9… about 11 hours ago GSK @GSK Congrats to GSK Maidenhead apprentice George Lawlor of @TiroRacing who represented England at the F1 in Schools Wor… twitter.com/i/web/status/9… about 13 hours ago GSK @GSK This week we manufactured the 100 millionth Ellipta inhaler! We're proud to be helping patients all over the globe… twitter.com/i/web/status/9… about 18 hours ago Follow us on Twitter Find out more Our products We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare Career opportunities at GSK Discover the work we do and the opportunities that exist, from research and development through to making our products available to those who need them Health for all Our medicines, vaccines and consumer healthcare products are improving quality of life for patients and consumers around the world. GSK Sitemap Terms of use Accessibility Cookie policy Privacy Statement GSK employees Contact us Partnerships Business to business Report a possible side effect Supplier portal Modern Slavery Act statement (PDF) © 2001-2017 GlaxoSmithKline plc. All rights reserved. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.

GSK Menu Corporate reporting Find out how GSK is performing with our Annual Report, including a financial summary, and Responsible Business Supplement. Annual Report 2016 View the summary report. Download sections and the full report. Responsible Business Supplement 2016 Download our Responsible Business Supplement. 2016 Form 20-F (PDF) Download our Form 20-F. Corporate reporting archive Archive of Annual Reports and Corporate Responsibility Reports dating back to 2000. GSK Sitemap Terms of use Accessibility Cookie policy Privacy Statement GSK employees Contact us Partnerships Business to business Report a possible side effect Supplier portal Modern Slavery Act statement (PDF) © 2001-2017 GlaxoSmithKline plc. All rights reserved. GlaxoSmithKline plc. Registered in England and Wales No. 3888792. Registered office: 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom.